Nuveen Asset Management, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 133 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$16,278,575
-24.4%
353,959
-5.5%
0.01%
-14.3%
Q2 2023$21,523,607
+180210.0%
374,519
+17.7%
0.01%
+75.0%
Q1 2023$11,937
+10.9%
318,324
-17.1%
0.00%0.0%
Q4 2022$10,759
-99.9%
384,005
-7.8%
0.00%
-20.0%
Q3 2022$11,706,000
-43.1%
416,607
-29.5%
0.01%
-37.5%
Q2 2022$20,555,000
+21.6%
590,824
+23.9%
0.01%
+60.0%
Q1 2022$16,899,000
+104.5%
476,675
+24.4%
0.01%
+150.0%
Q4 2021$8,262,000
+20.2%
383,227
+2.5%
0.00%0.0%
Q3 2021$6,871,000
-18.7%
374,052
-10.8%
0.00%
-33.3%
Q2 2021$8,450,000
+163.0%
419,137
+139.0%
0.00%
+200.0%
Q1 2021$3,213,000
-14.4%
175,388
-6.0%
0.00%0.0%
Q4 2020$3,752,000
-2.5%
186,560
-9.1%
0.00%0.0%
Q3 2020$3,847,000
-7.2%
205,186
+11.2%
0.00%
-50.0%
Q2 2020$4,145,000
+102.5%
184,535
+33.8%
0.00%
+100.0%
Q1 2020$2,047,000
-23.3%
137,955
-0.3%
0.00%0.0%
Q4 2019$2,669,000
-55.6%
138,345
-54.4%
0.00%
-50.0%
Q3 2019$6,016,000
-50.4%
303,371
-47.2%
0.00%
-60.0%
Q2 2019$12,134,000574,7830.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
EAM Investors, LLC 173,018$3,187,0000.42%
GLOBEFLEX CAPITAL L P 50,686$934,0000.23%
KALMAR INVESTMENTS INC /DE/ 240,648$4,433,0000.23%
ESSEX INVESTMENT MANAGEMENT CO LLC 63,661$1,173,0000.19%
OBERWEIS ASSET MANAGEMENT INC/ 27,200$501,0000.15%
Invictus RG 11,950$220,0000.15%
ACADIAN ASSET MANAGEMENT LLC 1,502,151$27,668,0000.13%
FOX RUN MANAGEMENT, L.L.C. 12,600$232,0000.12%
Piermont Capital Management Inc. 26,153$482,0000.11%
FEDERATED HERMES, INC. 1,344,684$24,769,0000.07%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders